Cell Signaling Technology

ACF1 Antibody

#6255 · $317

100
Citing papers
5.7k
Combined citations
Supplier page Find this product

Research areas

HER2/EGFR in Cancer Research14PI3K/AKT/mTOR signaling in cancer8Immune Response and Inflammation8interferon and immune responses7Cancer-related molecular mechanisms research7Cytokine Signaling Pathways and Interactions7Autophagy in Disease and Therapy7Lung Cancer Treatments and Mutations6

Papers citing this product

1
Study of the Biologic Effects of Lapatinib, a Reversible Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, on Tumor Growth and Survival Pathways in Patients With Advanced Malignancies
Journal of Clinical Oncology·2005·364 cit.·DOI
2
Protein Kinase C θ Inhibits Insulin Signaling by Phosphorylating IRS1 at Ser1101
Journal of Biological Chemistry·2004·352 cit.·DOI
3
Different mechanisms for resistance to trastuzumab versus lapatinib in HER2- positive breast cancers - role of estrogen receptor and HER2 reactivation
Breast Cancer Research·2011·283 cit.·DOI
4
Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells
Blood·2008·216 cit.·DOI
5
LncRNA EPB41L4A-AS1 regulates glycolysis and glutaminolysis by mediating nucleolar translocation of HDAC2
EBioMedicine·2019·175 cit.·DOI
6
Chemerin aggravates DSS-induced colitis by suppressing M2 macrophage polarization
Cellular and Molecular Immunology·2014·165 cit.·DOI
7
Hsp90 Chaperones Wild-type p53 Tumor Suppressor Protein
Journal of Biological Chemistry·2004·154 cit.·DOI
8
Innate immunity to RNA virus is regulated by temporal and reversible sumoylation of RIG-I and MDA5
The Journal of Experimental Medicine·2017·139 cit.·DOI
9
Intestinal CD103+CD11b− dendritic cells restrain colitis via IFN-γ-induced anti-inflammatory response in epithelial cells
Mucosal Immunology·2015·126 cit.·DOI
10
Long non-coding RNA MALAT1 for promoting metastasis and proliferation by acting as a ceRNA of miR-144-3p in osteosarcoma cells
Oncotarget·2017·123 cit.·DOI